Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: TEVA

Teva Pharmaceutical Industries Limited

Healthcare | Drug Manufacturers - Specialty & Generic

No licensed closing price on file for TEVA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$0.61

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a specialty and generic drug manufacturer. Figures from SEC EDGAR; updated 2026-10-19 19:09 UTC.

What Teva Pharmaceutical Industries Limited does

Teva is a biopharmaceutical company with a generics business, operating worldwide with headquarters in Israel and significant presence in the United States, Europe and many other markets. The company operates through three geographic segments—United States, Europe, and International Markets—each managing a full product portfolio including generic medicines, biosimilars, over-the-counter products, and innovative medicines.

Summarized from Teva Pharmaceutical Industries Limited’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$0.61
Return on equity17.83%
Debt/equity0.58

Revenue, margins & earnings

FY2021 Net income: $417MFY2021 Taxes & interest: $1.30BFY2021 Operating expenses: $5.88BFY2021 Cost of revenue: $8.28B$15.9BFY2021FY2022: net loss $2.45B on revenue $14.9B$14.9BFY2022FY2023: net loss $559M on revenue $15.8B$15.8BFY2023FY2024: net loss $1.64B on revenue $16.5B$16.5BFY2024FY2025 Net income: $1.41BFY2025 Taxes & interest: $747MFY2025 Operating expenses: $6.78BFY2025 Cost of revenue: $8.32B$17.3BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-22
  • 2026-09-22Interim Chief Legal OfficerStock Options (right to buy)Option exercise-4,503$156.3K
  • 2026-09-22Interim Chief Legal OfficerSale-4,503$174.2K
  • 2026-09-22Interim Chief Legal OfficerSale-314$12.2K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Teva Pharmaceutical Industries Limited do?

Teva is a biopharmaceutical company with a generics business, operating worldwide with headquarters in Israel and significant presence in the United States, Europe and many other markets.

When did TEVA last file with the SEC?

Teva Pharmaceutical Industries Limited's most recent SEC filing on record is a 10-Q filed 2026-07-29. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-19 19:09 UTC. This page is also available as JSON at /api/data?ticker=TEVA and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for TEVA and 5,000+ tickers.

Create a free account — keep TEVA
For your agent
GET /api/data?ticker=TEVA

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt